نتایج جستجو برای: codon 12 and 13

تعداد نتایج: 16938062  

Journal: :Cancer research 1988
F Raybaud T Noguchi I Marics J Adelaide J Planche M Batoz C Aubert O de Lapeyriere D Birnbaum

We have used an assay combining DNA-mediated gene transfer and tumorigenicity in Swiss athymic mice to look for activated ras genes in solid human sporadic melanomas. This assay can detect ras oncogenes mutated at codons 12, 13, or 61. We examined a panel of 13 independent surgical specimens of primary tumors and metastases. No H- or K-ras oncogenes were detected; an N-ras oncogene, mutated at ...

2013
Eric Bissada Olivier Abboud Zahi Abou Chacra Louis Guertin Xiaoduan Weng Phuc Félix Nguyen-Tan Jean-Claude Tabet Ève Thibaudeau Louise Lambert Marie-Lise Audet Bernard Fortin Denis Soulières

Background. RAS gene mutations have an impact on treatment response and overall prognosis for certain types of cancer. Objectives. To determine the prevalence and impact of K-RAS codons 12 and 13 mutations in patients with locally advanced HNSCC treated with primary or adjuvant chemo-radiation. Methods. 428 consecutive patients were treated with chemo-radiation therapy and followed for a median...

Journal: :Human pathology 2017
Yoshifumi Shimada Ryoma Yagi Hitoshi Kameyama Masayuki Nagahashi Hiroshi Ichikawa Yosuke Tajima Takuma Okamura Mae Nakano Masato Nakano Yo Sato Takeaki Matsuzawa Jun Sakata Takashi Kobayashi Hitoshi Nogami Satoshi Maruyama Yasumasa Takii Takashi Kawasaki Kei-Ichi Homma Hiroshi Izutsu Keisuke Kodama Jennifer E Ring Alexei Protopopov Stephen Lyle Shujiro Okuda Kohei Akazawa Toshifumi Wakai

HER2-targeted therapy is considered effective for KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (CRC). In general, HER2 status is determined by the use of immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH). Comprehensive genomic sequencing (CGS) enables the detection of gene mutations and copy number alterations including KRAS mutation and HER2 amp...

2006
Wendy L. Cerny Kathy A. Mangold Dante G. Scarpelli

K-ra.v oncogene mutation has been shown to be a frequent event in pancreatic ductal adenocarcinomas induced by the carcinogen V-nitroso-bis(2-oxopropyl)amine in the hamster. The present study exam ines the mutational status of the K-r«.v oncogene in lesions that precede the appearance of invasive ductal adenocarcinomas. Syrian golden ham sters (80-100 g) received 12 weekly doses of 15 mg/kg A'...

Journal: :BioTechniques 1998
K R Mitchell D Warshawsky

During the course of our research on chemically induced mutational spectra in mouse skin and liver tumors, we found the need to develop a sensitive method that would screen out nonmutated genes, related genes and pseudogenes. Although cold single-strand conformation polymorphism methods that used intron-specific primers existed, these methods were only sensitive to the point of 1 mutant in 33 n...

2006
Wendy L. Cerny Kathy A. Mangold Dante G. Scarpelli

K-ra.v oncogene mutation has been shown to be a frequent event in pancreatic ductal adenocarcinomas induced by the carcinogen V-nitroso-bis(2-oxopropyl)amine in the hamster. The present study exam ines the mutational status of the K-r«.v oncogene in lesions that precede the appearance of invasive ductal adenocarcinomas. Syrian golden ham sters (80-100 g) received 12 weekly doses of 15 mg/kg A'...

2005
Pedro Vizan Laszlo G. Boros Agnes Figueras Gabriel Capella Ramon Mangues Sara Bassilian Shu Lim Wai-Nang P. Lee Marta Cascante

Among K-ras mutations, codon 12 mutations have been identified as those conferring a more aggressive phenotype. This aggressiveness is primarily associated with slow proliferation but greatly increased resistance to apoptosis. Using transfected NIH3T3 fibroblasts with a mutated K-ras minigene either at codon 12 (K12) or at codon 13 (K13), and taking advantage of [1,2-C2]glucose tracer labeling,...

Journal: :modares journal of medical sciences: pathobiology 2006
houri edalat majid sadeghizadeh mansur jamali zavarehei

colorectal cancer (crc) is one of the most common cancers worldwide. understanding of the tumor behavior, in a much closer look, at the molecular level, results in a more effective treatment and accurate prognosis of the disease. from among various genes altered in colorectal cancer k-ras is assumed to be of diagnostic and prognostic significance. k-ras mutations are believed to be a critical e...

Journal: :Human immunology 2011
Petr Kocián Monika Šedivcová Jan Drgáč Kateřina Cerná Jiří Hoch Roman Kodet Jiřina Bartůňková Radek Špíšek Anna Fialová

The prognosis of newly diagnosed colorectal cancer patients relies mostly on tumor-node metastasis classification. However, analyses of tumor-infiltrating lymphocytes and several molecular markers have also shown promising prognostic value. Mutations in the proto-oncogene KRAS, which occur early in colorectal carcinogenesis, have been demonstrated to be common in human colorectal cancer (CRC); ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید